Loading viewer...
investor_presentation
Format: PDF investor_presentation
MindMed is a neuro-pharmaceutical drug development company focused on developing psychedelic-inspired medicines and non-hallucinogenic derivatives for brain health conditions. The company's lead program features zolunicant, a non-hallucinogenic synthetic derivative designed for clinical development under established regulatory frameworks. This March 2023 presentation outlines MindMed's product pipeline and development strategy in the emerging psychedelic medicine sector.
investor_presentation
20 Pages
Dominion Energy
investor_presentation
PBF Energy
investor_presentation
Bharat Forge Limited